Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 7, 2002, Pages 3023-3028

  Seppälä Lindroos, Anneli ^a   Vehkavaara, Satu ^a   Häkkinen, Anna Maija ^b   Goto, Takashi ^c   Westerbacka, Jukka ^a   Sovijärvi, Anssi ^a   Halavaara, Juha ^a   Yki Järvinen, Hannele ^a,c  

^a Divisions of Diabetes ^*  (Finland)

^b Departments of Oncology   (Italy)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GLUCOSE; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FAT CONTENT; FATTY ACID BLOOD LEVEL; FATTY LIVER; GENETIC VARIABILITY; GLUCONEOGENESIS; GLUCOSE CLAMP TECHNIQUE; GLUCOSE METABOLISM; GLUCOSE UTILIZATION; HUMAN; HYPERINSULINEMIA; HYPERTRIGLYCERIDEMIA; INSULIN INFUSION; INSULIN SENSITIVITY; MALE; OBESITY; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SYSTOLIC BLOOD PRESSURE;

ADIPOSE TISSUE; ADULT; FATTY ACIDS, NONESTERIFIED; GLUCOSE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; LIVER; MALE; MIDDLE AGED; OSMOLAR CONCENTRATION; REFERENCE VALUES;

EID: 0036312905     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.87.7.3023     Document Type: Article

References (40)

1. Mechanism of insulin resistance in A-ZIP/F-1 fatless mice
2. Troglitazone action is independent of adipose tissue
3. PPARγ is required for placental, cardiac, and adipose tissue development
4. Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: Model for congenital generalized lipodystrophy
5. Adipose tissue deficiency, glucose intolerance, and increased atherosclerosis result from mutation in the mouse fatty liver dystrophy (fld) gene
6. Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice
7. Lipoatrophy revisited
8. Intramyocellular lipid is associated with resistance to in vivo insulin actions on glucose uptake, antilipolysis, and early insulin signaling pathways in human skeletal muscle
9. Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients
10. Clinical features and natural history of nonalcoholic steatosis syndromes
11. Association of nonalcoholic fatty liver disease with insulin resistance
12. Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factors
13. Liver pathology and the metabolic syndrome X in severe obesity
14. Liver steatosis and its relation to plasma haemostatic factors in apparently healthy men-role of the metabolic syndrome
15. Nonalcoholic steatohepatitis: An expanded clinical entity
16. Nonalcoholic steatohepatitis
17. Glucose clamp technique: A method for quantifying insulin secretion and resistance
18. Quantification of liver fat using magnetic resonance spectroscopy
19. No reduction in in total hepatic glucose output by inhibition of gluconeogenesis with ethanol in NIDDM patients
20. Influences of glucose loading and of injected insulin on hepatic glucose output
21. A new and rapid method for the determination of glucose by measurement of rate of oxygen consumption
22. Radioimmunological determination of human C-peptide in serum
23. Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassay
24. A microfluorometric method for the determination of free fatty acids in plasma
25. Rapid chromatographic quantitation of glycosylated haemoglobins
26. Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus
27. Kinetics of glucose disposal in whole body and across the forearm in man
28. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance
29. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction
30. Insulin action on in vivo glucose metabolism
31. MBFL nonalcoholic fatty liver disease and the risk of type 2 diabetes in the United States
32. Fatty liver-an additional and treatable feature of the insulin resistance syndrome
33. Visceral fat and insulin resistance-causative or correlative?
34. Splanchnic metabolism of free fatty acids and production of triglyserides of very low density lipoproteins in normotriglyceridemic and hypertriglyceridemic humans
35. Systemic and regional free fatty acid metabolism in type 2 diabetes
36. Systemic and regional free fatty acid metabolism in type 2 diabetes
37. Metabolic and nutritional considerations in nonalcoholic fatty liver
38. Demonstration of a novel feedback mechanism between FFA oxidation from intracellular and intravascular sources
39. 3H-(R)-2-bromopalmitate
40. Role of AMP-activated protein kinase in mechanism of metformin action